Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice

This article provides an updated review of the pharmacological profile and available efficacy and tolerability/safety data for vilazodone, one of the most recent antidepressant drugs to be approved in the USA for the treatment of major depressive disorder (MDD) in adults. The efficacy of vilazodone...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Mohit, Parry, Rebecca, Bobo, William V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206504/
https://www.ncbi.nlm.nih.gov/pubmed/35726313
http://dx.doi.org/10.2147/NDT.S279342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206504/
https://www.ncbi.nlm.nih.gov/pubmed/35726313
http://dx.doi.org/10.2147/NDT.S279342

Ejemplares similares